CMS modified NCD 203 (Ultrafiltration Monitor) effective March 7, 2026, clarifying Medicare coverage conditions for ultrafiltration monitoring during hemodialysis for ESRD patients. Here's what billing teams need to know before claims go out the door.
The Centers for Medicare & Medicaid Services updated NCD 203 under the Home Dialysis Supplies and Equipment benefit category. The policy distinguishes between covered ultrafiltration monitoring as a component of hemodialysis and non-covered standalone ultrafiltration — a distinction that will drive claim denials if your team doesn't have the documentation lined up. This policy does not list specific CPT or HCPCS codes, which creates its own set of billing complications (more on that below).
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Ultrafiltration Monitor |
| Policy Code | NCD 203 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Nephrology, dialysis facilities, home dialysis programs, ESRD billing teams |
| Key Action | Audit your hemodialysis claims to confirm ultrafiltration monitoring is documented as a component of conventional dialysis — not billed as a standalone service |
CMS Ultrafiltration Monitor Coverage Criteria and Medical Necessity Requirements 2026
NCD 203 is the National Coverage Determination governing Medicare coverage of the Ultrafiltration Monitor, a device used during hemodialysis to manage fluid removal rates in ESRD patients. The clinical problem it solves is real: overfiltration pulls too much fluid from body tissues, underfiltration leaves too much behind, and either creates serious risk for an already fragile patient population.
CMS covers the Ultrafiltration Monitor when it is used to calculate fluid rates for patients who present difficult fluid management problems. That phrase is load-bearing. Medical necessity under this coverage policy is not automatic for every ESRD patient on hemodialysis — it's case-by-case, meaning your documentation needs to establish why a given patient's fluid management is clinically complex enough to warrant the device.
The coverage policy places the Ultrafiltration Monitor under the Home Dialysis Supplies and Equipment benefit category. For billing teams, that categorization matters because it frames how reimbursement flows and what supporting documentation Medicare expects at the claim level.
No prior authorization requirements are explicitly stated in NCD 203, but the case-by-case medical necessity determination means you are effectively building a prior auth-quality record every time this device is used. If your documentation doesn't articulate the specific fluid management difficulty, you're exposed on audit.
CMS Ultrafiltration Monitor Exclusions and Non-Covered Indications
Here's where the policy draws a hard line: ultrafiltration performed independent of conventional dialysis is considered experimental. Technology designed exclusively for standalone ultrafiltration — meaning not as part of a hemodialysis session — is not covered under Medicare.
This is the most consequential distinction in NCD 203. The Ultrafiltration Monitor is covered only when it functions as a component of hemodialysis. The moment the clinical use separates from conventional dialysis, you're in experimental territory, and the claim will not be reimbursed.
Some newer ultrafiltration devices are designed specifically for isolated ultrafiltration — used in heart failure management, for example, to remove excess fluid without dialysis. If your facility uses any such technology, do not bill it under the expectation that NCD 203 coverage applies. It doesn't. Talk to your compliance officer before billing those cases under Medicare.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Ultrafiltration monitoring as a component of hemodialysis in ESRD patients with difficult fluid management | Covered | No specific codes listed in NCD 203 | Medical necessity determined case-by-case; documentation must support "difficult fluid management" |
| Ultrafiltration independent of conventional dialysis | Not Covered / Experimental | No specific codes listed in NCD 203 | Technology designed exclusively for standalone ultrafiltration is excluded from Medicare coverage |
CMS Ultrafiltration Monitor Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit existing hemodialysis claims before March 7, 2026. Pull any claims where an Ultrafiltration Monitor is involved and confirm each one is documented as a component of conventional hemodialysis — not a standalone service. If your charge capture doesn't distinguish between the two, fix that now. |
| 2 | Standardize your "difficult fluid management" documentation language. CMS's medical necessity standard is case-by-case, which means clinical notes need to explain why each individual patient presents fluid management challenges. Generic hemodialysis notes won't carry this. Work with your medical director to establish a documentation template that explicitly captures the complexity. |
| 3 | Flag any standalone ultrafiltration cases immediately. If your facility performs isolated ultrafiltration — particularly for heart failure patients — those cases fall outside NCD 203 coverage entirely. Pull them from your standard ESRD billing workflow and loop in your compliance officer to determine the appropriate path for those claims. |
| 4 | Resolve the code gap proactively. NCD 203 does not list specific CPT or HCPCS codes. That's not unusual for older NCDs, but it does mean your billing team needs to confirm with your MAC (Medicare Administrative Contractor) which codes your region accepts for the Ultrafiltration Monitor under hemodialysis billing. Don't assume — call your MAC or submit a coverage inquiry before the effective date. |
| 5 | Update your denial management protocol. Claim denials tied to ultrafiltration will typically cite experimental/investigational status or failed medical necessity criteria. Make sure your billing team knows the two denial pathways — standalone ultrafiltration (not coverable, don't appeal on coverage grounds) versus hemodialysis-component ultrafiltration with insufficient documentation (appealable with the right clinical record). These require different responses. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Ultrafiltration Monitor Under NCD 203
NCD 203 does not list specific CPT, HCPCS, or ICD-10 codes. This is a genuine gap in the policy as published, and it creates real billing friction.
Your best move is to contact your regional MAC directly and ask which billing codes they accept for the Ultrafiltration Monitor under hemodialysis claims. MACs sometimes publish local guidance or billing articles that supplement NCDs without specific code lists. Check the CMS website for any associated claims processing instructions, which NCD 203 cross-references but does not reproduce in the policy itself.
Do not fabricate code assignments or rely on codes used by other facilities without MAC confirmation. The absence of listed codes in the published policy is not a license to apply codes by inference — it's a documentation and inquiry requirement your billing team needs to satisfy before the March 7, 2026 effective date.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.